Trending Market News

U.S. Treasury yields rose on Monday following renewed military strikes between the U.S. and Iran near the Strait of Hormuz, dampening hopes for a ceasefire deal. The 10-year Treasury yield climbed more than 1 basis point to 4.4729%, while oil prices surged over 4% on heightened geopolitical tensions.

• The 2-year Treasury yield rose more than 2 basis points to 4.0390%, while the 30-year yield held steady at 4.9958%
• Oil prices jumped sharply with U.S. crude up 4% to $90.92 and Brent crude rising 3.6% to $94.37 amid supply concerns near the Strait of Hormuz
• The ISM manufacturing PMI for May is expected at 53, up from April's 52.7, as investors monitor inflation signals in economic data

The U.S. FDA has approved Shionogi's oral antiviral Ensitrelvir (brand name Xocova) for preventive treatment of individuals exposed to COVID-19. This marks the first oral medication clinically proven to help prevent symptomatic COVID-19 after exposure, regardless of vaccination status. The approval's financial impact has already been factored into Shionogi's earnings forecast for fiscal year ending March 2027.

• Xocova is the first and only oral option clinically proven to prevent symptomatic COVID-19 after exposure, working regardless of vaccination status
• Shionogi has already incorporated the financial impact of the FDA approval into its earnings forecast for the fiscal year ending March 2027
• Shionogi's stock rose 0.9% following the announcement

Tesla registrations in Sweden increased 71% year-over-year in May, reaching 858 vehicles, according to data from Mobility Sweden. The significant growth indicates strengthening demand for Tesla vehicles in the Swedish market.

• Total Tesla registrations reached 858 vehicles in May, up from approximately 502 vehicles in May of the previous year
• The 71% year-over-year growth suggests Tesla is gaining market share in Sweden despite past labor-related challenges in the region

German retail sales declined by 0.3% in April compared to the previous month, according to data released on June 1. The drop was smaller than the 0.5% decrease that analysts had forecast, suggesting slightly more resilient consumer spending than expected.

• Retail sales fell 0.3% month-over-month in April, beating analyst expectations of a 0.5% decline
• The better-than-expected performance indicates German consumer demand may be holding up more than anticipated
• Further details on the retail sales data are expected from Germany's federal statistics office

Nvidia announced partnerships with humanoid robot makers globally, including China's Unitree, to build standardized robots for academic researchers. The collaboration involves Unitree providing robot bodies, Singapore's Sharpa supplying hands, and Nvidia contributing computing chips with enhanced cybersecurity features. This comes despite U.S. lawmakers raising concerns about Unitree's ties to the Chinese government and military.

• Nvidia is partnering with Unitree (China), plus unnamed companies in the U.S., Europe, and South Korea to create research-focused humanoid robots with standardized components
• U.S. lawmakers have introduced legislation to ban purchases of Unitree robots by researchers receiving federal funding due to alleged Chinese government and military connections
• Nvidia's Blackwell chips will integrate security features like secure boot and confidential computing to prevent malicious code execution and unauthorized data transfers from the robots

Nvidia announced its entry into the PC processor market with the N1X Arm-based chip, integrated into its RTX Spark superchip, which will debut in laptops from Microsoft, Dell, HP, ASUS, Lenovo, and MSI this fall. This marks Nvidia's expansion beyond AI data center chips into the PC market traditionally dominated by Intel, AMD, and Qualcomm. The company also announced its Vera CPU for data centers is now in full production with early customers including OpenAI, Anthropic, and SpaceX.

• The RTX Spark superchip combines Nvidia's Blackwell GPU with the custom N1X CPU (made by TSMC using 3-nanometer technology) and 128GB unified memory, targeting creators, AI developers, and gamers in premium laptops as thin as 14mm.
• Nvidia plans over 30 laptops and 10 desktops featuring the new chip, representing what CEO Jensen Huang called 'the first completely re-engineered, reinvented line of PCs that has happened in 40 years.'
• The Vera CPU for data centers can produce tokens 1.8 times faster than x86 processors and is being adopted by OpenAI, Anthropic, SpaceX's xAI, Dell, and others, with Nvidia calling it 'our new major growth driver' in what it projects will be a $200 billion CPU market.

China's manufacturing activity expanded in May according to a private survey, with the Caixin PMI reaching 51.8 and beating the expected 51.6. This contrasts with official government data showing weaker momentum, as China's official manufacturing PMI fell to 50 from 50.3 in April, marking the lowest level since February.

• The Caixin China General Manufacturing PMI came in at 51.8 in May, above the 50 threshold that separates expansion from contraction
• Official manufacturing PMI declined to 50 from 50.3 in April, the lowest reading since February's 49
• The divergence between private and official surveys suggests mixed signals about China's manufacturing sector recovery amid subdued growth and increased services activity

Nvidia CEO Jensen Huang will keynote the Computex trade show in Taipei on Monday with a major AI-focused speech, following his recent announcement of plans to invest around $150 billion annually in Taiwan. The speech comes as Nvidia, now a $5 trillion chipmaker, positions Taiwan as central to the AI revolution and builds a new headquarters there set to open in 2030.

• Huang is expected to discuss Nvidia's latest AI products including the Vera Rubin computing platform and Vera CPU, plus efforts in robotics and autonomous driving markets
• The company is investing approximately $150 billion per year in Taiwan and building a headquarters near key supplier TSMC, operational by 2030
• Nvidia is developing CPUs that would compete with Intel and AMD, with chips designed for AI-powered consumer hardware expected about two years after initial development

Oil prices rose more than 2% on Monday after Israel ordered troops to move deeper into Lebanon to battle Hezbollah, despite a ceasefire announced over six weeks ago. The increase reversed Friday's decline when markets had anticipated a U.S.-Iran ceasefire agreement.

• U.S. crude futures climbed 2.71% to $89.73 per barrel, while Brent futures rose 2.27% to $93.19 per barrel as of 1017 GMT
• The escalation in Lebanon involves Israeli forces engaging Iranian-backed Hezbollah militants in violation of a previously announced ceasefire
• Both Brent and WTI had fallen approximately 1.8% and 1.7% respectively on Friday on expectations of a U.S.-Iran ceasefire deal

Berkshire Hathaway announced it will acquire homebuilder Taylor Morrison Home Corporation for $8.5 billion in enterprise value. The deal values Taylor Morrison at $72.50 per common share. This acquisition expands Berkshire's presence in the residential construction sector.

• The acquisition price is set at $72.50 per common share of Taylor Morrison
• The transaction represents an $8.5 billion enterprise value for the homebuilder
• The deal was jointly announced by both companies on Sunday, May 31

Former Barclays CEO Jes Staley has agreed to be interviewed on July 23 by the House Oversight and Government Reform Committee about his relationship with sex offender Jeffrey Epstein. Staley resigned from Barclays in 2021 after a UK regulator investigated how he characterized his Epstein ties, and was later fined over $2 million and banned from UK financial management roles. The interview is part of a broader congressional inquiry that has included other high-profile figures connected to Epstein.

• Staley was a friend of Epstein during his time as a JPMorgan executive, where Epstein was a major client of the private wealth divisions Staley managed
• JPMorgan paid $290 million to Epstein victims in 2023 and $75 million to the U.S. Virgin Islands to settle lawsuits alleging the bank facilitated Epstein's crimes
• The Oversight Committee has already interviewed Bill Clinton, Hillary Clinton, Commerce Secretary Howard Lutnick, and former AG Pam Bondi, with additional interviews scheduled for Bill Gates (June 10) and others

Revolution Medicine's experimental pancreatic cancer drug daraxonrasib doubled survival time to 13.2 months versus 6.7 months with chemotherapy in a 500-person trial of patients who had failed initial treatment. The once-daily pill reduced the risk of death by 60% and improved quality of life enough that some patients resumed abandoned activities. The drug targets RAS mutations present in up to 90% of pancreatic cancers and has received FDA priority review.

• Daraxonrasib halted or reversed tumor progression in nearly 33% of patients versus 10% with chemotherapy, with tumors shrinking or disappearing in 31.6% versus 11.2% respectively
• While 86.3% of patients experienced rash, side effects were largely manageable with only 1.2% discontinuing treatment due to adverse events compared to 11.2% on chemotherapy
• The drug represents the first in a new class called RAS(ON) inhibitors and is already being tested in earlier-stage disease and combination therapies to extend survival benefits

Johnson & Johnson's prostate cancer drug Erleada, combined with hormone therapy before and after surgery, significantly improved outcomes in a late-stage trial of over 2,000 high-risk patients. The treatment made patients nine times more likely to have little to no detectable cancer at surgery and reduced disease progression or death risk by 20%. J&J plans to seek expanded regulatory approvals for this 'paradigm changing' approach to treating the roughly 40% of U.S. prostate cancer patients classified as high-risk.

• 8.9% of patients on the Erleada combination had little to no cancer at surgery versus only 1% on hormone therapy alone, with the treatment reducing recurrence or death risk by 20%
• Extended treatment (one full year) nearly doubled the time before patients needed additional therapy to over six years and reduced recurrence/death risk by 29%
• The drug would be the first androgen receptor pathway inhibitor approved for localized high-risk prostate cancer, addressing a major unmet need as nearly half of patients currently see cancer return after standard surgery and radiation

President Trump signed an executive order to accelerate research into psychedelic therapies for mental health conditions like PTSD and depression, marking a reversal from his first administration's stricter stance on controlled substances. The FDA issued priority review vouchers to three companies developing psychedelic treatments, sending investor interest surging. However, safety concerns and questions about whether political momentum is outpacing scientific rigor remain significant issues.

• MDMA-assisted therapy showed 71% of severe PTSD patients no longer met diagnostic criteria in clinical trials, though the FDA rejected approval in 2024 citing study design concerns and need for additional data
• The executive order specifically mentions ibogaine, which has not undergone large-scale U.S. trials and carries serious cardiovascular risks, raising researcher concerns about standards being relaxed for political reasons
• Critics suggest the timing may be politically motivated to regain veteran support ahead of midterm elections, particularly as the administration pursues VA staffing cuts

An experimental lung cancer drug called ivonescimab, developed by Akeso and Summit Therapeutics, reduced death risk by 34% in a Phase 3 trial conducted in China, extending median survival by four months compared to standard treatment. The bispecific antibody targets both PD-1 (like Merck's Keytruda) and VEGF (like Roche's Avastin), representing a potentially significant advancement for hard-to-treat squamous non-small-cell lung cancer patients.

• Patients receiving ivonescimab plus chemotherapy lived a median of 27.9 months versus 23.7 months for those on standard PD-1 immunotherapy plus chemotherapy, a four-month survival improvement
• Bleeding complications occurred in nearly 25% of ivonescimab patients (twice the control group rate), raising safety concerns particularly for squamous lung cancer patients whose tumors are near major blood vessels
• Questions remain about whether results from the China-only trial will translate to Western populations, with a global Phase 3 study (Harmoni-3) expected to report results in the second half of this year

SoftBank Group announced plans to invest up to €75 billion (approximately $87 billion) to expand data center capacity in France, targeting up to 5 gigawatts of additional capacity. This represents SoftBank's largest AI infrastructure investment in Europe and aligns with France's ambition to become a leading destination in the AI value chain.

• The first phase will build data centers in Dunkirk, Bosquel, and Bouchain to deliver 3.1 gigawatts of capacity to the Hauts-de-France region by 2031
• French economic minister Roland Lescure cited the investment as supporting President Macron's goal to position France as a leader across the AI value chain
• SoftBank has also announced data center plans in the United States, including a facility in Ohio, despite ongoing environmental and electrical grid concerns in that market

Yum Brands is in exclusive negotiations to sell its Pizza Hut chain to private equity firm LongRange Capital, according to Bloomberg News. LongRange recently won exclusivity over competing bidders including Sycamore Partners. While discussions are advancing and a deal could materialize within weeks, no agreement is guaranteed.

• Private equity firm LongRange Capital entered exclusivity with Yum Brands in recent days, outbidding rivals including Sycamore Partners
• The potential transaction could be finalized in several weeks, though there is no guarantee negotiations will result in a completed deal
• Neither Yum Brands, LongRange Capital, nor Sycamore Partners provided immediate comment on the reported negotiations

U.S. investment firm Castlelake is in early stages of considering a potential acquisition bid for British budget airline Easyjet. No formal approach has been made to Easyjet's board, and there is no certainty a deal will materialize. Under UK takeover rules, Castlelake must submit a firm offer by June 26 or withdraw.

• Castlelake has not yet approached Easyjet's board and no offer terms have been determined
• UK takeover regulations require Castlelake to make a firm offer or walk away by June 26
• The potential deal involves a major U.S. investment firm targeting one of Britain's leading budget carriers

Universal Music Group's board rejected a takeover proposal from Bill Ackman's Pershing Square on May 29, stating the offer fundamentally undervalues the company. Pershing Square had proposed acquiring Universal Music through a vehicle valuing the company at approximately €30.40 per share in April. Universal, which represents major artists including Taylor Swift and Billie Eilish, plans to move its listing from Amsterdam to New York to attract broader investor participation and achieve higher valuations.

• Pershing Square's April proposal valued Universal Music at around €30.40 per share, which the board deemed materially inadequate
• Universal Music represents major global artists including Taylor Swift, Billie Eilish, and Kendrick Lamar
• The company plans to relocate its stock listing from Amsterdam to New York to enable index fund ownership and improve earnings and valuation prospects

U.S. crude oil production held steady at 13.7 million barrels per day in March 2026, according to the EIA, though output in Texas fell to a four-month low of 5.78 million bpd. Production is expected to increase in subsequent months as operators respond to elevated oil prices around $88 per barrel driven by conflict with Iran that began in late February.

• Texas crude production dropped to 5.78 million bpd (four-month low) while New Mexico held steady at 2.31 million bpd; together the states' Permian Basin accounts for roughly half of U.S. crude output
• U.S. natural gas production rose to 135.52 billion cubic feet per day in March, up from 134.63 bcfd in February, with Texas setting a new record at 38.68 bcfd
• U.S. crude and product demand fell to 20.38 million bpd, the lowest since November, though demand was still up 2.2% year-over-year